Converge Bio is a biotechnology firm focused on integrating AI and machine learning into drug discovery and research processes. They specialize in developing tools that help companies effectively utilize biology-focused large language models (LLMs) by enhancing their data and providing insights into complex biological interactions. Their platform enables researchers to gain explainable results while generating new sequences to improve research outcomes.